DavidJRawlingsMD

PubMed

• Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reduceburden in mice.
  Malika Hale, Kennidy K Takehara, Christopher D Thouvenel, Dina A Moustafa, Andrea Repele
  Biorxiv. 2024-10-09
• 1 citations
  Blunting specific T-dependent antibody responses with engineered "decoy" B cells.
  Ragan A Pitner, Jaime L Chao, Noelle P Dahl, Meng-Ni Fan, Xiaohe Cai
  Molecular Therapy. 2024-10-02
• 8 citations
  Dual-locus, dual-HDR editing permits efficient generation of antigen-specific regulatory T cells with robust suppressive activity.
  Martina S Hunt, Soo Jung Yang, Emma Mortensen, Ahmad Boukhris, Jane Buckner
  Molecular Therapy. 2023-10-04

Journal Articles

• Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells  
  David J Rawlings, Shaun W Jackson, The Journal of Immunology

Abstracts/Posters

• Enabling Gene-Edited, Regulatory-like, T Cells (edTreg) for Treatment of IPEX and Other Autoimmune Disorders
  David J. Rawlings, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Manufacture and In Vivo Support of Gene-Edited, Regulatory-like, T-Cells (edTreg) Using a Synthetic IL2 Receptor
  David J. Rawlings, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019